{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-25-009214","form_type":"8-K","ticker":"NXTC","cik":"0001661059","company_name":"NextCure, Inc.","filed_at":"2025-07-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.585595+00:00","generated_at":"2026-05-18T06:40:43.641818+00:00","sec_items":["3.03","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"NextCure effects 1:12 reverse stock split effective July 14, 2025","bullets":["Reverse stock split ratio 1:12, effective 12:01 a.m. ET on July 14, 2025.","Stockholders approved split ratio range of 1:5 to 1:15; Board chose 1:12.","No fractional shares; cash payment for fractional shares based on closing price prior to effective date.","Authorized shares remain 100 million; all outstanding options, warrants, and equity plans adjusted proportionally.","Common stock continues trading under ticker NXTC on Nasdaq Global Select Market."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-25-009214","json":"https://secwatch.observer/filing/0001558370-25-009214.json","markdown":"https://secwatch.observer/filing/0001558370-25-009214.md","text":"https://secwatch.observer/filing/0001558370-25-009214.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1661059/000155837025009214/0001558370-25-009214-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1661059/000155837025009214/nxtc-20250714x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T06:40:43.641818+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"488a07f1512deb099559445c8b5f292b23b0bc47","claim":"NextCure, Inc.: Amendment to Certificate of Incorporation to effect a 1:12 reverse stock split (effective 2025-07-14).","evidence_excerpt":"On July 14, 2025, NextCure, Inc., a Delaware corporation (the “ Company ”), effected a one-for-twelve (1:12) reverse stock split (“ Reverse Stock Split ”) of the Company’s common stock, par value $0.001 (the “ Common Stock ”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1661059/000155837025009214/0001558370-25-009214-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-07-14"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}